Recently, increasing evidence suggests that neuroinflammation may be a critical factor in the development of Parkinson’s disease (PD) in addition to the ratio of acetylcholine/dopamine because dopaminergic neurons are particularly vulnerable to inflammatory attack. In this study, we investigated whether botulinum neurotoxin A (BoNT-A) was effective for the treatment of PD through its anti-neuroinflammatory effects and the modulation of acetylcholine and dopamine release. We found that BoNT-A ameliorated MPTP and 6-OHDA-induced PD progression, reduced acetylcholine release, levels of IL-1β, IL-6 and TNF-α as well as GFAP expression, but enhanced dopamine release and tyrosine hydroxylase expression. These results indicated that BoNT-A had beneficial effects on MPTP or 6-OHDA-induced PD-like behavior impairments via its anti-neuroinflammation properties, recovering dopamine, and reducing acetylcholine release.

Objective: Predictive tools such as the Glasgow Blatchford Score (GBS) and Pre-Rockall Score (PRS) have been used to foresee risks for gastrointestinal patients. This study was undertaken to determine the usefulness of the various available predictive tools in a vulnerable population. Methods: Data of patients with vulnerable upper gastrointestinal bleeding, who visited the emergency room from January 1, 2017 to December 31, 2018, were retrospectively examined. The GBS and PRS values were determined for all patients. Predictions of therapeutic endoscopy were evaluated with the area under curve (AUC) in the receiver operatory characteristic (ROC) curve. Results: A total of 152 patients were included in the study, 46 of whom required therapeutic endoscopes. In the area below the ROC curve, higher GBS values were obtained as compared to PRS in predicting therapeutic endoscopy (AUC, 0.726; 95% confidence interval [CI], 0.648-0.795 vs. 0.705; 95% CI, 0.626-0.776; P=0.689, respectively), transfusion (AUC, 0.861; 95% CI, 0.796-0.912 vs. 0.715; 95% CI, 0.637-0.786; P=0.001, respectively), and 30-day mortality (AUC, 0.698; 95% CI, 0.618-0.770 vs. 0.622; 95% CI, 0.540-0.699; P=0.351, respectively). Considering GBS 0, we determined with 100% sensitivity and 4.72% specificity that endoscopic treatment is redundant. Conclusion Compared to PRS, GBS excelled in predicting interventional treatment (endoscopy, transfusion) of vulnerable upper gastrointestinal patients, as well as the 30-day mortality. GBS is more useful in predicting low-risk patients that do not require treatment endoscopy, and is therefore a suitable procedure for outpatient care.

Objective: Predictive tools such as the Glasgow Blatchford Score (GBS) and Pre-Rockall Score (PRS) have been used to foresee risks for gastrointestinal patients. This study was undertaken to determine the usefulness of the various available predictive tools in a vulnerable population. Methods: Data of patients with vulnerable upper gastrointestinal bleeding, who visited the emergency room from January 1, 2017 to December 31, 2018, were retrospectively examined. The GBS and PRS values were determined for all patients. Predictions of therapeutic endoscopy were evaluated with the area under curve (AUC) in the receiver operatory characteristic (ROC) curve. Results: A total of 152 patients were included in the study, 46 of whom required therapeutic endoscopes. In the area below the ROC curve, higher GBS values were obtained as compared to PRS in predicting therapeutic endoscopy (AUC, 0.726; 95% confidence interval [CI], 0.648-0.795 vs. 0.705; 95% CI, 0.626-0.776; P=0.689, respectively), transfusion (AUC, 0.861; 95% CI, 0.796-0.912 vs. 0.715; 95% CI, 0.637-0.786; P=0.001, respectively), and 30-day mortality (AUC, 0.698; 95% CI, 0.618-0.770 vs. 0.622; 95% CI, 0.540-0.699; P=0.351, respectively). Considering GBS 0, we determined with 100% sensitivity and 4.72% specificity that endoscopic treatment is redundant. Conclusion Compared to PRS, GBS excelled in predicting interventional treatment (endoscopy, transfusion) of vulnerable upper gastrointestinal patients, as well as the 30-day mortality. GBS is more useful in predicting low-risk patients that do not require treatment endoscopy, and is therefore a suitable procedure for outpatient care.

BACKGROUND/AIMS: Currently, the videofluoroscopic swallowing study (VFSS) is the standard tool for evaluating dysphagia. We evaluated whether the addition of endoscopist-directed flexible endoscopic evaluation of swallowing (FEES) to VFSS could improve the detection rates of penetration, aspiration, and pharyngeal residue, compared the diagnostic efficacy between VFSS and endoscopist-directed FEES and assessed the adverse events of the FEES. METHODS: In single tertiary referral center, a retrospective analysis of prospectively collected data was conducted. Fifty consecutive patients suspected of oropharyngeal dysphagia were enrolled in this study between January 2012 and July 2012. RESULTS: The agreement in the detection of penetration and aspiration between VFSS and FEES of viscous food (kappa=0.34; 95% confidence interval [CI], 0.15 to 0.53) and liquid food (kappa=0.22; 95% CI, 0.02 to 0.42) was "fair." The agreement in the detection of pharyngeal residue between the two tests was "substantial" with viscous food (kappa=0.63; 95% CI, 0.41 to 0.94) and "fair" with liquid food (kappa=0.37; 95% CI, 0.10 to 0.63). Adding FEES to VFSS significantly increased the detection rates of penetration, aspiration, and pharyngeal residue. No severe adverse events were noted during FEES, except for two cases of epistaxis, which stopped spontaneously without requiring any packing. CONCLUSIONS: This study demonstrated that the addition of endoscopist-directed FEES to VFSS increased the detection rates of penetration, aspiration, and pharyngeal residue.
Aged ; Deglutition/*physiology ; Deglutition Disorders/*diagnosis/radiography ; Female ; Fluoroscopy/methods ; Humans ; Laryngoscopy/*methods/statistics & numerical data ; Male ; Middle Aged ; *Pharynx/radiography ; Reproducibility of Results ; Retrospective Studies ; Video Recording

PURPOSE: Neonatal neuroblastoma (NBL) is the most common malignant tumor in neonates, but there have been few studies about it. The purpose of this study was to investigate the clinical features of NBL and to compare prenatal and postnatal diagnosed groups. METHODS: Nineteen patients who were diagnosed with NBL prenatally or within 28 days after birth from February 1986 to February 2013 in Seoul National University Hospital were enrolled in the study. The patients were categorized according to the International Neuroblastoma Staging System (INSS) and Children's Oncology Group (COG). Retrospective medical-record reviews were performed on these patients. The operative date, complication, pathological stage, and overall survival of the prenatally diagnosed group and the postpartum diagnosed group were compared. RESULTS: Tumor was detected via prenatal ultrasonography in 8 patients (42.1%), and 11 patients (57.9%) were diagnosed within 28 days after birth. Based on INSS, the patients were divided into the stage I (n=8), stage II (n=1), stage III (n=3), stage IV (n=4), and stage IVs (n=3) groups, respectively. Based on COG, on the other hand, the patients were divided into the low-risk (n=8), intermediate-risk (n=8), and high-risk (n=3) groups. The postoperative complication rate was 29%. One patient died from complications from chemotherapy. The other 18 patients' mean follow-up period was 77.7 months. The differences between the postoperative complication rate, proportion of early-stage tumor, and overall survival of the prenatal and postnatal groups were not statistically significant (p=0.446, p=0.607, p=0.414). CONCLUSION: NBL showed favorable outcomes but relatively higher postoperative complications. There seem to be no significant statistical differences in the postoperative complications, proportion of early-stage tumor, and overall survival between the prenatally diagnosed group and the postpartum diagnosed group.
Drug Therapy ; Follow-Up Studies ; Hand ; Humans ; Infant, Newborn ; Neuroblastoma* ; Parturition ; Postoperative Complications ; Postpartum Period* ; Prenatal Diagnosis ; Retrospective Studies ; Seoul ; Ultrasonography, Prenatal

Kaposi sarcoma is a rare tumor originated from skin in patients with immune suppressive illness like as acquired immunodeficiency syndrome (AIDS) or organ transplantation. It may be widely disseminated internally such as digestive or respiratory organ. In Korean patients with AIDS, Kaposi sarcoma is rarely seen rather than western countries. The reason is unknown. Although few cases of Kaposi sarcoma in patients with AIDS had been described in the Korean literatures, multi-organ involved cases were extremely rare. We describe a case of old AIDS patient in whom Kaposi sarcoma had affected multi-organs including esophagus, stomach, duodenum, colon, bronchi and skin.
Acquired Immunodeficiency Syndrome ; Bronchi* ; Colon ; Duodenum ; Esophagus ; Gastrointestinal Tract* ; Humans ; Organ Transplantation ; Sarcoma, Kaposi* ; Skin ; Stomach ; Transplants

Systemic manifestation of tuberculosis is common, but tuberculous biliary obstruction of the pancreas and a colon adenocarcinoma with combined colonic tuberculosis is an uncommon disorder. We encountered a case of the above condition in 63-year-old male that was admitted to our hospital because of fever, diffuse abdominal pain and rigidity. Abdominal computed tomography showed biliary and pancreatic duct dilatation with left colonic wall thickening and surrounding peritoneal infiltration. Emergency segmental resection of the descending colon with intraoperative T-tube choledochostomy was performed due to the colon mass and biliary obstruction. A colonofiberoscopy was performed for low abdominal pain and hematochezia at 12 days after surgery. It showed multiple colonic ulcerations with a partial stricture. A colonic biopsy showed granulomatous inflammation with acid-fast bacilli. The cause of the biliary obstruction was also revealed as pancreatic tuberculosis by an intraoperative pancreatic and mesenteric biopsy. The patient improved after antituberculous treatment and the patient has been in good health until the last outpatient follow-up visit.
Abdominal Pain ; Adenocarcinoma* ; Biopsy ; Choledochostomy ; Colitis* ; Colon* ; Colon, Descending ; Colonic Neoplasms ; Constriction, Pathologic ; Dilatation ; Emergencies ; Fever ; Follow-Up Studies ; Gastrointestinal Hemorrhage ; Humans ; Inflammation ; Male ; Middle Aged ; Outpatients ; Pancreas ; Pancreatic Ducts ; Tuberculosis* ; Ulcer

BACKGROUND: This study compared the bronchodilator efficacy and safety of tiotropium inhalation capsules (18microgram once daily) with a ipratropium metered dose inhaler (2 puffs of 20microgram q.i.d.) in patients with chronic obstructive pulmonary disease (COPD). METHOD: After the initial screening assessment and a two-week run-in period, patients received either tiotropium 18microgram once daily or ipratropium 40microgram four times daily over a period of 4 weeks in a double blind, double dummy, parallel group study. The outcome measures were the lung function, the daily records of the peak expiratory flow rate (PEFR), the patients' questionnaire, and the use of concomitant salbutamol. The forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC) were measured 5 minutes before inhalation, and 0.5, 1, 2 and 3 hours after inhaling the study drug on days 0, 14 and 28. RESULT: In 16 centers, 134 patients with a mean (SD) age of 66 (7) years and a predicted FEV1 of 42 (12)% were analyzed. The trough FEV1 response was significantly higher in the tiotropium group than in the ipratropium group after a four-week treatment period. The weekly mean morning PEFR of the tiotropium group was consistently higher than that of the ipratropium group during the 4-week treatment period with differences ranging from 12.52 to 13.88 l/min, which were statistically significant. Tiotropium was well tolerated by the COPD patients during the 4-week treatment period and had a similar safety profile to ipratropium. CONCLUSION: This study shows that tiotropium administrated once daily has a superior bronchodilator effect with a similar safety profile in treating COPD patients compared with ipratropium, inhaled four times daily.
Adult* ; Albuterol ; Bronchodilator Agents ; Capsules ; Forced Expiratory Volume ; Humans ; Inhalation ; Ipratropium* ; Lung ; Mass Screening ; Metered Dose Inhalers ; Outcome Assessment (Health Care) ; Peak Expiratory Flow Rate ; Pulmonary Disease, Chronic Obstructive* ; Surveys and Questionnaires ; Vital Capacity ; Tiotropium Bromide

BACKGROUND/AIM: Salmonella can cause an asymptomatic intestinal carrier state or clinical disease. The most common clinical manifestation is enterocolitis. In diagnosis of salmonellosis, total colonoscopy is not perfomed routinely, but to diagnose and treat the some of salmonellosis presented with acute massive rectal bleeding, fever, diarrhea, or abdominal pain resulted from vague cause. We evaluated colonoscopic findings of salmonella colitis, and the efficacy of the colonoscopic biopsy and tissue culture compared with conventional culture of blood, urine, and stool, retrospectively. METHODS: Six cases were performed total colonoscopy. We analyzed the correlation between clinical onset and colonoscopic findings and compared the efficacy of conventional culture methods. RESULTS: Colonoscopic findings were summarized as; 1. Major involved sites ere terminal ileum, cecum, and ascending colon, but in some cases, entire colon was involved. 2. Mucosal changes were nonspecific. Of variable culture methods, colonoscopic tissue culture was the most sensitive for identification of causative organisms. CONCLUSIONS: Colonoscopic features are not useful to diagnose salmonella colitis, because the findings are similar to those in inflammatory bowel disease, and there was no correlations between colonoscopic findings and symptom onset and severity. But, it is safe and useful method to isolate the causative organism of acute infectious colitis.
Abdominal Pain ; Biopsy ; Carrier State ; Cecum ; Colitis* ; Colon ; Colon, Ascending ; Colonoscopy* ; Diagnosis ; Diarrhea ; Enterocolitis ; Fever ; Hemorrhage ; Ileum ; Inflammatory Bowel Diseases ; Retrospective Studies ; Salmonella Infections ; Salmonella*

BACKGROUND/AIM: Salmonella can cause an asymptomatic intestinal carrier state or clinical disease. The most common clinical manifestation is enterocolitis. In diagnosis of salmonellosis, total colonoscopy is not perfomed routinely, but to diagnose and treat the some of salmonellosis presented with acute massive rectal bleeding, fever, diarrhea, or abdominal pain resulted from vague cause. We evaluated colonoscopic findings of salmonella colitis, and the efficacy of the colonoscopic biopsy and tissue culture compared with conventional culture of blood, urine, and stool, retrospectively. METHODS: Six cases were performed total colonoscopy. We analyzed the correlation between clinical onset and colonoscopic findings and compared the efficacy of conventional culture methods. RESULTS: Colonoscopic findings were summarized as; 1. Major involved sites ere terminal ileum, cecum, and ascending colon, but in some cases, entire colon was involved. 2. Mucosal changes were nonspecific. Of variable culture methods, colonoscopic tissue culture was the most sensitive for identification of causative organisms. CONCLUSIONS: Colonoscopic features are not useful to diagnose salmonella colitis, because the findings are similar to those in inflammatory bowel disease, and there was no correlations between colonoscopic findings and symptom onset and severity. But, it is safe and useful method to isolate the causative organism of acute infectious colitis.
Abdominal Pain ; Biopsy ; Carrier State ; Cecum ; Colitis* ; Colon ; Colon, Ascending ; Colonoscopy* ; Diagnosis ; Diarrhea ; Enterocolitis ; Fever ; Hemorrhage ; Ileum ; Inflammatory Bowel Diseases ; Retrospective Studies ; Salmonella Infections ; Salmonella*